Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that the United States (U.S.) Food and Drug Administration ...
Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that the United States (U.S.) Food ...
The FDA granted priority review to pembrolizumab for neoadjuvant and adjuvant use in head and neck squamous cell carcinoma, ...
Last year marked an all-time record of 18 Food and Drug Administration (FDA) biosimilar approvals, bringing the total number ...
Q4 2024 Earnings Conference Call February 25, 2025 8:00 AM ETCompany ParticipantsMichael Dale - Chairman and Chief ...
Keytruda demonstrated a statistically significant and clinically meaningful improvement in event-free survival and major ...
The US Food and Drug Administration (FDA) has accepted for priority review a new supplemental Biologics License Application ...
17h
Hosted on MSNFDA accepts BMS’ Opdivo-Yervoy combo sBLA for colorectal cancerThe US Food and Drug Administration (FDA) has accepted Bristol Myers Squibb’s (BMS) supplemental biologics licence ...
This Press Release updates an error in the sub headline Strategic Partnership: Royal Biologics and Coldplasmatech Revolutionize Complex Wound Care HACKENSACK, N ...
Royal Biologics and Coldplasmatech Revolutionize Complex Wound Careyal Biologics and Coldplasmatech Revolutioniz ...
Precigen (PGEN) announced the FDA has accepted the company’s biologics license application, or BLA, for PRGN-2012, an investigational ...
Merck (MRK) announced the FDA has accepted for priority review a new supplemental Biologics License Application seeking approval for keytruda – ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results